A drug traditionally used as an anaesthetic and sometimes used recreationally could be effective in preventing suicide in severely depressed patients, says a UNSW academic who has trialled the drug.
New Australian research demonstrates the potential public health impact of mental health prevention programs delivered in the workplace.
A new resource is being launched to tackle mental health problems among people with an intellectual disability and to improve the system that is currently failing them.
Researchers at UNSW are conducting the first ever trial of a brief online intervention to treat combined depression and alcohol misuse in young people.
Thousands of children with the most common health complaints, including asthma and diabetes, will be part of a UNSW study assessing the suitability of healthcare.
Widespread confusion about what constitutes grief, ‘normaI’ depression and clinical depression risks being exacerbated under psychiatry's new classification system, Scientia Professor Gordon Parker warns.
Harnessing genetic science to head off major depressive disorder, the world’s leading cause of disability, is fraught with controversy, writes Dr Alex Wilde.
A world-first study is under way looking at the genetic predisposition of some people to become depressed after bereavement.
Ketamine may be useful as an antidepressant in urgent situations – where the patient is seriously depressed and acutely suicidal – and where other treatments have failed, writes Colleen Loo.
At least one in three patients with depression won’t respond well to a series of treatments and specialists in the field have joined together to outline practical treatments to tackle the issue.